Difference between revisions of "Part:BBa K3111103:Design"

 
m (→‎Source)
 
(2 intermediate revisions by the same user not shown)
Line 13: Line 13:
 
===Source===
 
===Source===
  
−
-
+
Encapsulin was isolated from <I>Thermotoga maritima</i> (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099). Sequence was taken from <partinfo>BBa_K2686002</partinfo> (without the stop codon as that would disable fusion on the C-terminus).
  
 
===References===
 
===References===
 +
 +
Moon, H., Lee, J., Min, J. and Kang, S. (2014). Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform. Biomacromolecules, 15(10), pp.3794-3801.

Latest revision as of 11:27, 15 October 2019


T. maritima encapsulin (6-His) with a StrepII-tag expressed under T7 promoter


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 183
    Illegal BglII site found at 598
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 1013
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal SapI.rc site found at 532
    Illegal SapI.rc site found at 563


Design Notes

-


Source

Encapsulin was isolated from Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099). Sequence was taken from BBa_K2686002 (without the stop codon as that would disable fusion on the C-terminus).

References

Moon, H., Lee, J., Min, J. and Kang, S. (2014). Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform. Biomacromolecules, 15(10), pp.3794-3801.